- Home
- AKRO vs OPCH Comparison
AKRO vs OPCH Comparison
Compare AKRO & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- OPCH
- Stock Information
- Founded
- AKRO 2017
- OPCH N/A
- Country
- AKRO United States
- OPCH United States
- Employees
- AKRO N/A
- OPCH N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- OPCH Medical/Nursing Services
- Sector
- AKRO Health Care
- OPCH Health Care
- Exchange
- AKRO Nasdaq
- OPCH Nasdaq
- Market Cap
- AKRO 3.9B
- OPCH 4.6B
- IPO Year
- AKRO 2019
- OPCH N/A
- Fundamental
- Price
- AKRO $45.02
- OPCH $29.06
- Analyst Decision
- AKRO Strong Buy
- OPCH Strong Buy
- Analyst Count
- AKRO 8
- OPCH 7
- Target Price
- AKRO $80.38
- OPCH $36.14
- AVG Volume (30 Days)
- AKRO 856.3K
- OPCH 1.8M
- Earning Date
- AKRO 08-08-2025
- OPCH 10-29-2025
- Dividend Yield
- AKRO N/A
- OPCH N/A
- EPS Growth
- AKRO N/A
- OPCH 5.29
- EPS
- AKRO N/A
- OPCH 1.26
- Revenue
- AKRO N/A
- OPCH $5,374,021,000.00
- Revenue This Year
- AKRO N/A
- OPCH $14.82
- Revenue Next Year
- AKRO N/A
- OPCH $8.49
- P/E Ratio
- AKRO N/A
- OPCH $22.64
- Revenue Growth
- AKRO N/A
- OPCH 17.07
- 52 Week Low
- AKRO $21.34
- OPCH $21.39
- 52 Week High
- AKRO $58.40
- OPCH $35.53
- Technical
- Relative Strength Index (RSI)
- AKRO 38.25
- OPCH 52.29
- Support Level
- AKRO $43.08
- OPCH $28.16
- Resistance Level
- AKRO $46.18
- OPCH $29.19
- Average True Range (ATR)
- AKRO 1.62
- OPCH 0.76
- MACD
- AKRO -0.30
- OPCH 0.17
- Stochastic Oscillator
- AKRO 29.56
- OPCH 87.93
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.